Data was normalized to ∆E1A HAdV and a non-specific antibody control. n=3 Figure S3 . hPaf1 is excluded from IFN regulated genes during WT HAdV infection. ChIP assays were performed on A549 cells 20 hours after infection with the indicated viruses at a MOI of 5. ChIP was then performed using a control anti-mouse antibody or antibodies specific for hBre1, Ube2b, E1A, or hPaf1. S4 . hPaf1 recruitment to the E2e, E3 and E4 promoters requires E1A and hBre1 and the interaction of E1A with hPaf1 requires hBre1. (A) hPaf1 ChIP was followed by re-ChIP with either hBre1 or E1A specific antibodies to determine co-occupancy at the E1A and E1B promoters. Data was normalized to ∆E1A HAdV and a non-specific antibody control. hPaf1 is not co-associated with E1A and hBre1 at these promoters. (B) hPaf1 recruitment to the E2e, E3 and E4 promoters requires hBre1. A549 cells were treated with a non-specific siRNA, or siRNA specific for hBre1, or hPaf1 prior to virus infection.
ChIP assays were then performed using hBre1 or hPaf1 specific antibodies. hPaf1 and hBre1 occupancy was then determined at the HAdV E1A, E1B, E2e, E3 and E4 promoters as described above. A statistically significant decrease from Ctrl siRNA treatment is indicated (* P<0.01) for B. (C) hPaf1
interacts with E1A and this is hBre1 dependent. A549 cells were treated with Ctrl or hBre1 specific siRNA and infected with WT or ΔE1A virus. Cells were collected after 20 hours. Lysates were immunoprecipitated with anti-E1A antibody and probed for hPaf1. n=2 Table S1 . List of primers used in this study. 
